| Ticker Details |
|
Shuttle Pharmaceuticals Holdings, Inc.
|
| IPO Date: |
August 31, 2022 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers - Specialty and Generic |
| Market Cap: |
$3.45M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.32 | 5.80%
|
| Avg Daily Range (30 D): |
$0.16 | 7.68%
|
| Avg Daily Range (90 D): |
$0.13 | 6.18%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.38M |
| Avg Daily Volume (30 D): |
4.83M |
| Avg Daily Volume (90 D): |
1.84M |
| Trade Size |
| Avg Trade Size (Sh.): |
79 |
| Avg Trade Size (Sh.) (30 D): |
149 |
| Avg Trade Size (Sh.) (90 D): |
148 |
| Institutional Trades |
| Total Institutional Trades: |
10 |
| Avg Institutional Trade: |
$.78M |
| Avg Institutional Trade (30 D): |
$.52M |
| Avg Institutional Trade (90 D): |
$.52M |
| Avg Institutional Trade Volume: |
M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.94M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
.12K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$75.89
|
$-1.05
|
|
|
Diluted EPS
|
$75.78
|
$-1.05
|
|
|
Revenue
|
$-5.6M
|
$M
|
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-11.09M
|
$-2.35M
|
$-3.71M
|
|
Operating Income / Loss
|
$-10.91M
|
$-2.27M
|
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-.66M
|
|
|
|
PE Ratio
|
0.01
|
|
|
| Splits |
|
Jun 16, 2025
|
1:25
|
|
Aug 13, 2024
|
1:8
|
|
|
|